Amgen Inc. (AMGN)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

$ 69.05
   
  • Change Today:
    $-0.05
  • 52 Week High: $71.64
  • 52 Week Low: $48.27
  • Currency: US Dollars
  • Shares Issued: 777.71m
  • Volume: 2,959,663
  • Market Cap: $53,701m
  • RiskGrade: 80
  • Beta: 0.63

Latest ShareCast News

Astra to back Amgen development

Date: Tuesday 03 Apr 2012

Anglo-Swedish drugs giant AstraZeneca is teaming up with US biotechnology company Amgen to jointly develop and bring to market a portfolio of clinical-stage inflammation treatments.

Amgen Inc. ShareCast News

US broker round-up 06-Mar-2012 ShareCast
US close: Stocks fall as Greek talks drag on 06-Feb-2012 ShareCast
US close: Stocks reverse on poor economic data 26-Jan-2012 ShareCast
Amgen to acquire Micromet for $1.16bn 26-Jan-2012 ShareCast
US close: Stocks rally on Eurozone developments 08-Nov-2011 ShareCast

Amgen Inc. Newspaper Links

SEP cashes in as US giant Amgen buys cancer drug... 26-Jan-2011 The Scotsman
Amgen Buys a Cancer Drug Maker 25-Jan-2011 New York Times
Tech Ticker 16-Dec-2010 BayArea.com
Amgen drug delayed spread of prostate cancer to ... 15-Dec-2010 LA Times
Business Briefing 24-Dec-2009 LA Times

Amgen Inc. Tips & Analysis

Stocks, oil prices fall on economic concerns 08-Jul-2009 LA Times
Wyeth Deal May Slow Pfizer Biotech Acquisitions 27-Jan-2009 New York Times
In Wyeth, Pfizer Sees a Drug Pipeline 27-Jan-2009 New York Times
Biotech Campaigns for Easier Access to Generic D... 13-Aug-2008 Washington Post
Stocks close down sharply as financials fall 29-Jul-2008 Wall Street Journal

Amgen Inc. News Wires

Nplate(TM) (Romiplostim) Receives Positive Opini... 21-Nov-2008 PR Newswire
Amgen, Takeda and Millennium Provide Update on P... 19-Nov-2008 PR Newswire
Amgen Positioned to Deliver Attractive Growth Ov... 07-Nov-2008 PR Newswire
Burrill Reports Biotech Hit By Market Jitters in... 01-Aug-2007 PR Newswire
Host Cities Announced for 2008 Amgen Tour of Cal... 25-Jul-2007 PR Newswire

Other Amgen Inc. News

Amgen Receives CHMP Positive Opinion for Prolia(... 18-Dec-2009 PR Newswire
Data Presented at San Antonio Breast Cancer Symp... 10-Dec-2009 PR Newswire
Amgen Presents Data From First Nplate(R) Study i... 07-Dec-2009 PR Newswire
Nplate(R) Data From MDS Studies Presented at ASH 06-Dec-2009 PR Newswire
Amgen Highlights Data to be Presented at ASH 30-Nov-2009 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Amgen Inc. Market Data

Currency US Dollars
Share Price $ 69.05
Change Today $ -0.05
% Change -0.07 %
52 Week High $71.64
52 Week Low $48.27
Volume 2,959,663
Shares Issued 777.71m
Market Cap $53,701m
Beta 0.63
RiskGrade 80

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 16
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-May-2012

Time Volume / Share Price
16:00 2,870 @ $69.05
16:00 297 @ $69.05
16:00 1,393 @ $69.05
15:59 100 @ $69.02
15:59 100 @ $69.02

Top of Page